Submit an Original Article

2 Things to Watch at MannKind Corporation (MNKD)

From Insider Monkey - Free Hedge Fund and Insider Trading Data
January 24, 2013 - 11:33am
With its fourth-quarter earnings report just around the corner, biotech company MannKind Corporation (NASDAQ:MNKD) continues to inch its way toward an FDA decision regarding its ultra-rapid inhalable insulin product Afrezza. With each passing day, the debate among investors rages on as to whether this product can ultimately gain approval and be commercially viable. In a brand [...]

Continue reading this article »

Share This Article:

Submit an Original Article

Wall Street Buzz

MOST POPULAR